The following statements are based on current expectations. These statements are forward-looking, and actual results may differ materially.
Microchip Consolidated Guidance | |||||||||
GAAP |
Non-GAAP
|
Non-GAAP1 | |||||||
Net Sales | $482.4 to $496.8 million | $482.4 to $496.8 million | |||||||
Gross Margin2 | 58.55% to 58.75% | $2.2 million | 59.0% to 59.2% | ||||||
Operating Expenses 2 | 33.45% to 33.85% | $32.1 to $33.0 million | 26.8% to 27.2% | ||||||
Other Expense | $7.8 million | $2.3 million | $5.5 million | ||||||
Income Tax Expense | 11.8% to 12.8% | $2.4 to $2.7 million | 10.5% to 11.5% | ||||||
Net Income | $97.1 to $104.0 million | $33.8 to $35.2 million | $130.9 to $139.2 million | ||||||
Diluted Common Shares
|
Approximately 221.7
|
Approximately 0.6
|
Approximately 221.1
|
||||||
Earnings per Diluted Share | 43 to 47 cents | Approximately 16 cents | 59 to 63 cents | ||||||
1 See the “Use of Non-GAAP Financial Measures” section of this release. |
|||||||||
2 Earnings per share have been calculated based on the diluted shares outstanding of Microchip on a consolidated basis. |
|||||||||
3 See Footnote 2 under the “Use of Non-GAAP Financial Measures” section of this release. |
|||||||||
- Microchip’s inventory days at March 31, 2014 are expected to be about 119 to 125 days. Our inventory position enables us to continue to service our customers with very short lead times while allowing us to control future capital expenditures. Our actual inventory level will depend on the inventory that our distributors decide to hold to support their customers, overall demand for our products and our production levels.
- Capital expenditures for the quarter ending March 31, 2014 are expected to be approximately $30 million. Capital expenditures for all of fiscal year 2014 are anticipated to be approximately $115 million. We are continuing to take actions to selectively invest in the equipment needed to support the expected growth of our new products and technologies.
- We expect net cash generation during the March quarter of approximately $135 million to $155 million prior to the dividend payment and our acquisition related activities.
1 |
Use of Non-GAAP Financial Measures: Our Non-GAAP adjustments, where applicable, include the effect of share-based compensation, expenses related to our acquisition activities (including intangible asset amortization, inventory valuation costs, restructuring costs, severance costs, earn-out adjustments and legal and other general and administrative expenses associated with acquisitions), and non-cash interest expense on our convertible debentures, gains on strategic investments, the related income tax implications of these items and nonrecurring tax events. |
|
We are required to estimate the cost of certain forms of share-based compensation, including employee stock options, restricted stock units and our employee stock purchase plan, and to record a commensurate expense in our income statement. Share-based compensation expense is a non-cash expense that varies in amount from period to period and is affected by the price of our stock at the date of grant. The price of our stock is affected by market forces that are difficult to predict and are not within the control of management. The non-GAAP adjustments related to the impact of our acquisitions, gains on strategic investments, nonrecurring tax events and a portion of our interest expense related to our convertible debentures are either non-cash expenses or non-recurring expenses related to such transactions. Accordingly, management excludes all of these items from its internal operating forecasts and models. | ||
We are using non-GAAP net sales, non-GAAP gross profit, non-GAAP gross profit percentage, non-GAAP operating expenses in dollars and as a percentage of sales including non-GAAP research and development expenses and non-GAAP selling, general and administrative expenses, non-GAAP operating income, non-GAAP other expense, net, non-GAAP income tax/tax rate, non-GAAP net income, and non-GAAP diluted earnings per share which exclude the items noted in the immediately preceding paragraph, as applicable, to permit additional analysis of our performance. | ||
Management believes these non-GAAP measures are useful to investors because they enhance the understanding of our historical financial performance and comparability between periods. Many of our investors have requested that we disclose this non-GAAP information because they believe it is useful in understanding our performance as it excludes non-cash and other charges that many investors feel may obscure our underlying operating results. Management uses these non-GAAP measures to manage and assess the profitability of our business. Specifically, we do not consider such items when developing and monitoring our budgets and spending. As described above, the economic substance behind our decision to exclude such items relates either to these charges being non-cash in nature, or to the one-time nature of the events. Our determination of the above non-GAAP measures might not be the same as similarly titled measures used by other companies, and it should not be construed as a substitute for amounts determined in accordance with GAAP. There are limitations associated with using non-GAAP measures, including that they exclude financial information that some may consider important in evaluating our performance. Management compensates for this by presenting information on both a GAAP and non-GAAP basis for investors and providing reconciliations of the GAAP and non-GAAP results. |
||
2 |
Diluted Common Shares Outstanding can vary for, among other things, the trading price of our common stock, the actual exercise of options or vesting of restricted stock units, the potential for incremental dilutive shares from our convertible debentures (additional information regarding our share count is available in the investor relations section of our website under the heading “Supplemental Financial Information”), and the repurchase or the issuance of stock. The diluted common shares outstanding presented in the guidance table above assumes an average Microchip stock price in the March 2014 quarter of $45 per share (however, we make no prediction as to what our actual share price will be for such period or any other period and we cannot estimate what our stock option exercise activity will be during the quarter). |
|
3 |
Generally, gross margin fluctuates over time, driven primarily by the mix of microcontrollers, analog products and memory products sold and licensing revenue; variances in manufacturing yields; fixed cost absorption; wafer fab loading levels; inventory reserves; pricing pressures in our non-proprietary product lines; and competitive and economic conditions. Operating expenses fluctuate over time, primarily due to net sales and profit levels. |
|
MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES | ||||||||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME | ||||||||||||||||||||||
(in thousands except per share amounts) | ||||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||||
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||||||||
Net sales | $ | 482,372 | $ | 416,047 | $ | 1,437,833 | $ | 1,151,479 | ||||||||||||||
Cost of sales | 199,652 | 215,619 | 599,676 | 552,059 | ||||||||||||||||||
Gross profit | 282,720 | 200,428 | 838,157 | 599,420 | ||||||||||||||||||
Operating expenses: | ||||||||||||||||||||||
Research and development | 76,341 | 71,377 | 227,680 | 184,285 | ||||||||||||||||||
Selling, general and administrative | 66,856 | 69,368 | 201,934 | 196,727 | ||||||||||||||||||
Amortization of acquired intangible assets | 21,804 | 39,711 | 73,225 | 71,615 | ||||||||||||||||||
Special charges | 801 | 2,559 | 2,491 | 24,953 | ||||||||||||||||||
165,802 | 183,015 | 505,330 | 477,580 | |||||||||||||||||||
Operating income | 116,918 | 17,413 | 332,827 | 121,840 | ||||||||||||||||||
Gains (losses) on equity method investments | 150 | (229 | ) | (211 | ) | (382 | ) | |||||||||||||||
Other expense, net | (4,480 | ) | (7,492 | ) | (18,486 | ) | (18,783 | ) | ||||||||||||||
Income before income taxes | 112,588 | 9,692 | 314,130 | 102,675 | ||||||||||||||||||
Income tax provision (benefit) | 7,187 | (481 | ) | 30,344 | 34,976 | |||||||||||||||||
Net income | $ | 105,401 | $ | 10,173 | $ | 283,786 | $ | 67,699 | ||||||||||||||
Basic net income per common share | $ | 0.53 | $ | 0.05 | $ | 1.43 | $ | 0.35 | ||||||||||||||
Diluted net income per common share | $ | 0.48 | $ | 0.05 | $ | 1.31 | $ | 0.33 | ||||||||||||||
Basic common shares outstanding | 198,759 | 194,958 | 197,845 | 194,157 | ||||||||||||||||||
Diluted common shares outstanding | 219,089 | 204,405 | 215,943 | 204,553 | ||||||||||||||||||
MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands) |
||||||||||
ASSETS | ||||||||||
December 31, | March 31, | |||||||||
2013 | 2013 | |||||||||
(Unaudited) | ||||||||||
Cash and short-term investments | $ | 1,307,402 | $ | 1,578,597 | ||||||
Accounts receivable, net | 224,273 | 229,955 | ||||||||
Inventories | 274,629 | 242,334 | ||||||||
Other current assets | 162,724 | 185,484 | ||||||||
Total current assets | 1,969,028 | 2,236,370 | ||||||||
Property, plant & equipment, net | 520,565 | 514,544 | ||||||||
Long-term investments | 723,925 | 257,450 | ||||||||
Other assets | 789,590 | 843,041 | ||||||||
Total assets | $ | 4,003,108 | $ | 3,851,405 | ||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||
Accounts payable and other current liabilities | $ | 158,926 | $ | 202,659 | ||||||
Short-term borrowings | 9,409 | - | ||||||||
Deferred income on shipments to distributors | 143,315 | 138,952 | ||||||||
Total current liabilities | 311,650 | 341,611 | ||||||||
Long-term line of credit | 300,000 | 620,000 | ||||||||
Long-term borrowings, net | 340,444 | - | ||||||||
Convertible debentures | 369,618 | 363,385 | ||||||||
Long-term income tax payable | 179,246 | 182,723 | ||||||||
Deferred tax liability | 388,620 | 388,250 | ||||||||
Other long-term liabilities | 38,422 | 21,966 | ||||||||
Stockholders’ equity | 2,075,108 | 1,933,470 | ||||||||
Total liabilities and stockholders’ equity | $ | 4,003,108 | $ | 3,851,405 | ||||||
MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES | ||||||||||||||||||||||
RECONCILIATION OF GAAP TO NON-GAAP MEASURES | ||||||||||||||||||||||
(in thousands except per share amounts and percentages) | ||||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||||
RECONCILIATION OF GAAP NET SALES TO NON-GAAP NET SALES | ||||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||
December 31, | December 31, | |||||||||||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||||||||
Net sales, as reported | $ | 482,372 | $ | 416,047 | $ | 1,437,833 | $ | 1,151,479 | ||||||||||||||
Distributor revenue recognition adjustment | - | - | - | 24,748 | ||||||||||||||||||
Non-GAAP net sales | $ | 482,372 | $ | 416,047 | $ | 1,437,833 | $ | 1,176,227 | ||||||||||||||
RECONCILIATION OF GAAP GROSS PROFIT TO NON-GAAP GROSS PROFIT | ||||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||
December 31, | December 31, | |||||||||||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||||||||
Gross profit, as reported | $ | 282,720 | $ | 200,428 | $ | 838,157 | $ | 599,420 | ||||||||||||||
Distributor revenue recognition adjustment | - | - | - | 15,868 | ||||||||||||||||||
Share-based compensation expense | 1,841 | 1,834 | 5,674 | 5,758 | ||||||||||||||||||
Acquisition-related acquired inventory valuation and other costs | 42 | 30,808 | 42 | 54,958 | ||||||||||||||||||
Non-GAAP gross profit | $ | 284,603 | $ | 233,070 | $ | 843,873 | $ | 676,004 | ||||||||||||||
Non-GAAP gross profit percentage | 59.0 | % | 56.0 | % | 58.7 | % | 57.5 | % | ||||||||||||||
RECONCILIATION OF GAAP RESEARCH AND DEVELOPMENT EXPENSES TO NON-GAAP RESEARCH AND DEVELOPMENT EXPENSES | ||||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||
December 31, | December 31, | |||||||||||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||||||||
Research and development expenses, as reported | $ | 76,341 | $ | 71,377 | $ | 227,680 | $ | 184,285 | ||||||||||||||
Share-based compensation expense | (6,141 | ) | (6,172 | ) | (18,762 | ) | (16,562 | ) | ||||||||||||||
Acquisition-related costs | - | - | - | (17 | ) | |||||||||||||||||
Non-GAAP research and development expenses | $ | 70,200 | $ | 65,205 | $ | 208,918 | $ | 167,706 | ||||||||||||||
Non-GAAP research and development expenses as a percentage of net sales | 14.6 | % | 15.7 | % | 14.5 | % | 14.3 | % | ||||||||||||||
RECONCILIATION OF GAAP SELLING, GENERAL AND ADMINISTRATIVE EXPENSES TO NON-GAAP SELLING, GENERAL AND ADMINISTRATIVE EXPENSES | ||||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||
December 31, | December 31, | |||||||||||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||||||||
Selling, general and administrative expenses, as reported | $ | 66,856 | $ | 69,368 | $ | 201,934 | $ | 196,727 | ||||||||||||||
Share-based compensation expense | (5,737 | ) | (6,114 | ) | (16,939 | ) | (22,339 | ) | ||||||||||||||
Acquisition-related costs | (503 | ) | (1,035 | ) | (1,774 | ) | (6,054 | ) | ||||||||||||||
Non-GAAP selling, general and administrative expenses | $ | 60,616 | $ | 62,219 | $ | 183,221 | $ | 168,334 | ||||||||||||||
Non-GAAP selling, general and administrative expenses as a percentage of net sales | 12.6 | % | 15.0 | % | 12.7 | % | 14.3 | % | ||||||||||||||
RECONCILIATION OF GAAP OPERATING EXPENSES TO NON-GAAP OPERATING EXPENSES | ||||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||
December 31, | December 31, | |||||||||||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||||||||
Operating expenses, as reported | $ | 165,802 | $ | 183,015 | $ | 505,330 | $ | 477,580 | ||||||||||||||
Share-based compensation expense | (11,878 | ) | (12,286 | ) | (35,701 | ) | (38,901 | ) | ||||||||||||||
Acquisition-related costs | (503 | ) | (1,035 | ) | (1,774 | ) | (6,071 | ) | ||||||||||||||
Amortization of acquired intangible assets | (21,804 | ) | (39,711 | ) | (73,225 | ) | (71,615 | ) | ||||||||||||||
Special charges | (801 | ) | (2,559 | ) | (2,491 | ) | (24,953 | ) | ||||||||||||||
Non-GAAP operating expenses | $ | 130,816 | $ | 127,424 | $ | 392,139 | $ | 336,040 | ||||||||||||||
Non-GAAP operating expenses as a percentage of net sales | 27.1 | % | 30.6 | % | 27.3 | % | 28.6 | % | ||||||||||||||
RECONCILIATION OF GAAP OPERATING INCOME TO NON-GAAP OPERATING INCOME | ||||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||
December 31, | December 31, | |||||||||||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||||||||
Operating income, as reported | $ | 116,918 | $ | 17,413 | $ | 332,827 | $ | 121,840 | ||||||||||||||
Distributor revenue recognition adjustment | - | - | - | 15,868 | ||||||||||||||||||
Share-based compensation expense | 13,719 | 14,120 | 41,375 | 44,659 | ||||||||||||||||||
Acquisition-related acquired inventory valuation and other costs | 545 | 31,843 | 1,816 | 61,029 | ||||||||||||||||||
Amortization of acquired intangible assets | 21,804 | 39,711 | 73,225 | 71,615 | ||||||||||||||||||
Special charges | 801 | 2,559 | 2,491 | 24,953 | ||||||||||||||||||
Non-GAAP operating income | $ | 153,787 | $ | 105,646 | $ | 451,734 | $ | 339,964 | ||||||||||||||
Non-GAAP operating income as a percentage of net sales | 31.9 | % | 25.4 | % | 31.4 | % | 28.9 | % | ||||||||||||||
RECONCILIATION OF GAAP OTHER EXPENSE, NET TO NON-GAAP OTHER EXPENSE, NET | ||||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||
December 31, | December 31, | |||||||||||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||||||||
Other expense, net, as reported | $ | (4,480 | ) | $ | (7,492 | ) | $ | (18,486 | ) | $ | (18,783 | ) | ||||||||||
Convertible debt non-cash interest expense | 2,286 | 2,089 | 6,682 | 6,106 | ||||||||||||||||||
Gain on shares of acquired company | (2,438 | ) | - | (2,438 | ) | - | ||||||||||||||||
Non-GAAP other expense, net | $ | (4,632 | ) | $ | (5,403 | ) | $ | (14,242 | ) | $ | (12,677 | ) | ||||||||||
Non-GAAP other expense, net, as a percentage of net sales | -1.0 | % | -1.3 | % | -1.0 | % | -1.1 | % | ||||||||||||||
RECONCILIATION OF GAAP INCOME TAX PROVISION (BENEFIT) TO NON-GAAP INCOME TAX PROVISION | ||||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||
December 31, | December 31, | |||||||||||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||||||||
Income tax provision (benefit), as reported | $ | 7,187 | $ | (481 | ) | $ | 30,344 | $ | 34,976 | |||||||||||||
Income tax rate, as reported | 6.4 | % |
-5.0 |
% | 9.7 | % | 34.1 | % | ||||||||||||||
Distributor revenue recognition adjustment | - | - | - | 3,404 | ||||||||||||||||||
Share-based compensation expense | 1,510 | 2,755 | 4,501 | 7,496 | ||||||||||||||||||
Acquisition-related acquired inventory valuation costs, intangible asset amortization and other costs | 392 | 7,416 | 1,172 | 12,803 | ||||||||||||||||||
Special charges | 300 | 1,367 | 933 | 12,843 | ||||||||||||||||||
Convertible debt non-cash interest expense | 856 | 784 | 2,502 | 2,291 | ||||||||||||||||||
Non-recurring tax events | 6,172 | 3,645 | 8,167 | (26,071 | ) | |||||||||||||||||
Non-GAAP income tax provision | $ | 16,417 | $ | 15,486 | $ | 47,619 | $ | 47,742 | ||||||||||||||
Non-GAAP income tax rate | 11.0 | % | 15.5 | % | 10.9 | % | 14.6 | % | ||||||||||||||
RECONCILIATION OF GAAP NET INCOME AND GAAP DILUTED NET INCOME PER SHARE TO NON-GAAP NET INCOME AND NON-GAAP DILUTED NET INCOME PER SHARE | ||||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||
December 31, | December 31, | |||||||||||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||||||||
Net income, as reported | $ | 105,401 | $ | 10,173 | $ | 283,786 | $ | 67,699 | ||||||||||||||
Distributor revenue recognition adjustment, net of tax effect | - | - | - | 12,464 | ||||||||||||||||||
Share-based compensation expense, net of tax effect | 12,209 | 11,365 | 36,874 | 37,163 | ||||||||||||||||||
Acquisition-related acquired inventory valuation costs, intangible asset amortization and other costs, net of tax effect | 21,957 | 64,138 | 73,869 | 119,841 | ||||||||||||||||||
Special charges, net of tax effect | 501 | 1,192 | 1,558 | 12,110 | ||||||||||||||||||
Gain on shares of acquired company | (2,438 | ) | - | (2,438 | ) | - | ||||||||||||||||
Convertible debt non-cash interest expense, net of tax effect | 1,430 | 1,305 | 4,180 | 3,815 | ||||||||||||||||||
Non-recurring tax events | (6,172 | ) | (3,645 | ) | (8,167 | ) | 26,071 | |||||||||||||||
Non-GAAP net income | $ | 132,888 | $ | 84,528 | $ | 389,662 | $ | 279,163 | ||||||||||||||
Non-GAAP net income as a percentage of net sales | 27.5 | % | 20.3 | % | 27.1 | % | 23.7 | % | ||||||||||||||
Diluted net income per share, as reported | $ | 0.48 | $ | 0.05 | $ | 1.31 | $ | 0.33 | ||||||||||||||
Non-GAAP diluted net income per share | $ | 0.61 | $ | 0.41 | $ | 1.81 | $ | 1.37 | ||||||||||||||
Diluted common shares outstanding, as reported | 219,089 | 204,405 | 215,943 | 204,553 | ||||||||||||||||||
Diluted common shares outstanding Non-GAAP | 218,371 | 204,123 | 215,251 | 204,231 | ||||||||||||||||||